Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial-Reference-Cited by-同舟云学术

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial

Published:2016-12 Issue:12 Volume:17 Page:1697-1708
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Al-Batran Salah-Eddin,Hofheinz Ralf D,Pauligk Claudia,Kopp Hans-Georg,Haag Georg Martin,Luley Kim Barbara,Meiler Johannes,Homann Nils,Lorenzen Sylvie,Schmalenberg Harald,Probst Stephan,Koenigsmann Michael,Egger Matthias,Prasnikar Nicole,Caca Karel,Trojan Jörg,Martens Uwe M,Block Andreas,Fischbach Wolfgang,Mahlberg Rolf,Clemens Michael,Illerhaus Gerald,Zirlik Katja,Behringer Dirk M,Schmiegel Wolff,Pohl Michael,Heike Michael,Ronellenfitsch Ulrich,Schuler Martin,Bechstein Wolf O,Königsrainer Alfred,Gaiser Timo,Schirmacher Peter,Hozaeel Wael,Reichart Alexander,Goetze Thorsten O,Sievert Mark,Jäger Elke,Mönig Stefan,Tannapfel Andrea

Funder

German Cancer Aid

Publisher

Elsevier BV

Subject

Oncology

Reference25 articles.

1. Prognostic implications of the seventh edition of the International Union Against Cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution;Reim;J Clin Oncol,2013

2. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

3. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;Ychou;J Clin Oncol,2011

4. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

5. Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data;Ronellenfitsch;Eur J Cancer,2013

Cited by 572 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics;Targeted Oncology;2024-09-13

2. Needs, preferences, and patient participation for a randomized controlled trial on postneoadjuvant complete tumor response: A qualitative study of patients with esophageal cancer;Supportive Care in Cancer;2024-09-11

3. Therapie des Magenkarzinoms und AEG – wie reihen sich klinische AIO-Studien in die Therapielandschaft ein?;Die Onkologie;2024-09-02

4. Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinoma;Pharmacological Research;2024-09

5. Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: A single-center experience;Surgery;2024-09